The Mexico Oral Anti-Diabetic Drug Market is projected to reach USD 2.01 billion by 2033, growing at a CAGR of 3.46% from 2023. This growth is driven by rising diabetes prevalence, improved healthcare access, and demand for effective oral treatments.

The Mexico Oral Anti-Diabetic Drug Market is projected to reach USD 2.01 billion by 2033, growing at a CAGR of 3.46% from 2023. This growth is driven by rising diabetes prevalence, improved healthcare access, and demand for effective oral treatments.